Lazanda

Product NDC
13913-013
11-digit product format
139130013
Labeler code
13913
Product ID
13913-013_c2b4b455-fd85-4767-baee-4d068f08e4e7
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
fentanyl citrate
Dosage form
SPRAY
Route
NASAL
Labeler
Depomed, Inc.
Application
NDA022569
Marketing category
NDA
Marketing start
2016-01-01
Marketing end
0000-00-00
Substance
FENTANYL CITRATE
Active strength
300 ug/1
Pharmacologic classes
Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule
CII
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
13913-013-01EA - Each13913-0130ef14c9a-407d-41f7-b501-c4c868b82d5812016-07-19